Medigen Biotechnology Corp
TPEX:3176
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medigen Biotechnology Corp
TPEX:3176
|
TW |
|
H
|
Huikwang Corp
TPEX:6508
|
TW |
|
Prodia Diagnostic Line Tbk PT
IDX:PRDL
|
ID |
|
T
|
Taiwan Allied Container Terminal Corp
TPEX:5601
|
TW |
|
P
|
Professional Computer Technology Ltd
TPEX:6270
|
TW |
|
F
|
Full Wang International Development Co Ltd
TPEX:6219
|
TW |
|
B
|
Bolan Castings Ltd
KAR:BCL
|
PK |
|
A
|
Allmind Holdings Corp
TPEX:2718
|
TW |
|
E
|
Enli Technology Co Ltd
TPEX:7728
|
TW |
|
C
|
Cigna Group
XMUN:CGN
|
US |
|
A
|
AimCore Technology Co Ltd
TPEX:3615
|
TW |
|
U
|
Ultra Chip Inc
TPEX:3141
|
TW |
|
S
|
Sinopower Semiconductor Inc
TPEX:6435
|
TW |
|
L
|
Lumosa Therapeutics Co Ltd
TPEX:6535
|
TW |
Bankruptcy Probability
Medigen Biotechnology Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Medigen Biotechnology Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
M
|
Medigen Biotechnology Corp
TPEX:3176
|
5.3B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
464.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
218B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Medigen Biotechnology Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Medigen Biotechnology Corp has total debt of 1.6B TWD. This includes both short-term (130.6m TWD) and long-term (1.5B TWD) debt.
You can find a full breakdown on its Balance Sheet.